Flanking markers of cystatin C (CST3) gene do not show association with alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 27, Issue 4, 2009, Pages 318-321

  Helisalmi, Seppo ^a   Väkevä, Antti ^a   Hiltunen, Mikko ^a   Soininen, Hilkka ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Association; Case control study; CST3

Indexed keywords

APOLIPOPROTEIN E; CYSTATIN C;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; FINLAND; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COHORT STUDIES; CYSTATIN C; FEMALE; FINLAND; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT;

EID: 62049085195     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209278     Document Type: Article

References (12)

1. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP: Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:1359-1366.
2. Vinters HV, Nishimura GS, Secor DL, Pardridge WM: Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am J Pathol 1990;137:233-240.
3. Levy E, Lopez-Otin C, Ghiso J, Geltner D, Frangione B: Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 1989;169:1771-1778.
4. Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, Staufen-biel M, Levy E, Grubb A, Jucker M: Cystatin Cmodulates cerebral β-amyloidosis. Nat Genet 2007;39:1437-1439.
5. Goddard KA, Olson JM, Payami H, van der Voet M, Kuivaniemi H, Tromp G: Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease. Neurogenetics 2004;5:121-128.
6. Blacker D, Haines JL, Rodes L, Terwedow H, Go RC, Harrell LE, Perry RT, Bassett SS, Chase G, Meyers D, Albert MS, Tanzi R: ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 1997;48:139-147.
7. Helisalmi S, Tarvainen T, Vepsäläinen S, Koivisto AM, Hiltunen M, Soininen H: Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease. Neurosci Lett 2008; 441: 233-236.
8. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
9. Finckh U, von der Kammer H, Velden J, Michel T, And resen B, Deng A, Zha ng J, Müller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, Benussi L, Stoppe G, Reiss J, Miserez AR, Staehelin HB, Rebeck GW, Hyman BT, Binetti G, Hock C, Growdon JH, Nitsch RM: Genetic association of a cystatin c gene polymorphism with late-onset Alzheimer disease. Arch Neurol 2000;57:1579-1583.
10. Mi W, Pawlik M, Sastre M, Jung SS, Radvin-sky DS, Klein AM, Sommer J, Schmidt SD, Nixon RA, Mathews PM, Levy E: Cystain Cinhibits amyloid- β deposition in Alzheimer's disease mouse models. Nat Genet 2007; 39:1440-1442.
11. Abrahamson M, Olafsson I, Palsdottir A, Ulvsbäck M, Lundwall A, Jensson O, Grubb A: Structure and expression of the human cystatin c gene. Biochem J 1990;268:287-294.
12. Chuo LJ, Sheu WHH, Pai MC, Kuo YM: Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease. Dement Geriatr Cogn Disord 2007;23: 251-257.